Skip to main content

Table 1 Demographics of the 72-h URVNA and URVA patients

From: The risk factors of the 72-h unscheduled return visit admission to emergency department in adults below 50 years old

 

Age ≤ 50

50 ~ 60

p value

60 ~ 70

p value

70 ~ 80

p value

Age ≥ 80

URVNA

URVA

p value

URVNA

URVA

URVNA

URVA

URVNA

URVA

URVNA

URVA

p value

n

2221

554

 

1020

402

 

1349

727

 

968

599

 

708

935

 

Sex (%)

 Male

998 (44.93)

259 (46.75)

0.47

573 (56.21)

255 (63.4)

0.01

648 (48.02)

397 (54.61)

 < 0.001

465 (48.07)

354 (59.12)

 < 0.001

368 (51.97)

457 (48.88)

0.23

 Female

1223 (55.07)

295 (53.25)

0.47

447 (43.89)

147 (36.6)

0.01

701 (52.98)

330 (45.39)

0.004

503 (51.93)

245 (40.88)

 < 0.001

340 (48.03)

478 (51.12)

0.23

 Length of stay

4.33 (6.07)

6.63 (8.31)

 < 0.001

5.43 (7.92)

7.76 (10.01)

 < 0.001

5.57 (7.30)

7.93 (8.54)

 < 0.001

6.46 (8.11)

8.26 (8.80)

 < 0.001

9.12 (9.19)

6.27 (7.37)

 < 0.001

Triage (%)

 Severe

217 (9.77)

117 (21.12)

 < 0.001

151 (14.80)

108 (26.87)

 < 0.001

217 (16.09)

239 (32.87)

 < 0.001

190 (19.63)

203 (33.89)

 < 0.001

176 (18.82)

287 (40.54)

0.01

 Non-severe

2004 (90.23)

437 (78.88)

 < 0.001

869 (85.20)

294 (73.13)

 < 0.001

1132 (83.91)

488 (67.13)

 < 0.001

778 (80.37)

396 (66.11)

 < 0.001

532 (81.18)

748 (59.46)

0.02

Vital Sign (mean (SD))

 Temp

37.02 (2.31)

37.22 (1.95)

0.04

36.78 (1.85)

36.99 (2.15)

0.08

36.75 (1.66)

37.02 (2.27)

0.01

36.70 (1.85)

37.13 (1.92)

 < 0.001

36.77 (1.43)

37.11 (0.96)

 < 0.001

 Breath

19.12 (3.13)

19.50 (4.07)

0.04

19.05 (2.32)

19.41 (3.25)

0.04

19.13 (2.29)

19.91 (4.25)

 < 0.001

19.21 (2.55)

19.75 (3.06)

 < 0.001

19.49 (3.53)

20.48 (4.51)

 < 0.001

 SBP

132.46 (22.87)

129.92 (23.81)

0.02

143.75 (27.32)

138.25 (27.94)

 < 0.001

146.64 (28.23)

139.80 (30.99)

 < 0.001

148.42 (29.57)

139.10 (27.73)

 < 0.001

146.45 (30.43)

141.65 (30.67)

0.001

 DBP

85.29 (16.22)

82.89 (17.29)

0.003

89.66 (17.38)

86.39 (17.52)

0.001

87.30 (16.54)

83.91 (20.94)

 < 0.001

83.53 (16.66)

78.59 (16.89)

 < 0.001

77.46 (17.25)

76.72 (17.60)

0.40

 Pulse

95.78 (20.66)

100.98 (21.78)

 < 0.001

92.01 (19.41)

97.88 (22.38)

 < 0.001

90.27 (19.63)

97.36 (23.42)

 < 0.001

87.23 (18.05)

92.25 (21.48)

 < 0.001

85.28 (18.83)

88.86 (21.18)

 < 0.001

Index Score (mean (SD))

 RAPS

2.33 (1.45)

2.53 (1.56)

 < 0.001

2.69 (1.53)

2.77 (1.65)

0.39

2.60 (1.53)

2.83 (1.83)

0.003

2.54 (1.52)

2.55 (1.65)

0.78

2.41 (1.60)

2.69 (1.74)

 < 0.001

 qSOFA

1.09 (0.32)

1.17 (0.42)

 < 0.001

1.11 (0.33)

1.20 (0.47)

 < 0.001

1.11 (0.34)

1.24 (0.52)

 < 0.001

1.14 (0.39)

1.28 (0.51)

 < 0.001

1.20 (0.45)

1.41 (0.63)

 < 0.001

 CCI

1.22 (0.64)

1.59 (1.00)

 < 0.001

2.74 (1.15)

3.36 (1.35)

 < 0.001

4.09 (1.32)

4.64 (1.45)

 < 0.001

5.35 (1.36)

5.77 (1.43)

 < 0.001

6.47 (1.49)

6.79 (1.59)

 < 0.001

 GCS

14.87 (1.10)

14.80 (1.24)

0.22

14.87 (0.95)

14.76 (1.27)

0.13

14.88 (0.84)

14.72 (1.37)

0.003

14.81 (1.16)

14.68 (1.32)

0.06

14.75 (1.12)

14.29 (1.90)

 < 0.001

 Shock Index (HR/SBP)

0.74 (0.18)

0.80 (0.21)

 < 0.001

0.66 (0.18)

0.74 (0.23)

 < 0.001

0.64 (0.19)

0.73 (0.24)

 < 0.001

0.61 (0.18)

0.68 (0.20)

 < 0.001

0.61 (0.19)

0.65 (0.21)

 < 0.001

Comorbidity (%)

 MI

2 (0.09)

3 (0.54)

0.09

4 (0.39)

10 (2.49)

 < 0.001

8 (0.59)

16 (2.20)

0.002

5 (0.52)

16 (2.67)

 < 0.001

7 (0.75)

14 (1.98)

0.49

 CHF

14 (0.63)

16 (2.89)

 < 0.001

14 (1.37)

11 (2.74)

0.12

44 (3.26)

45 (6.19)

0.002

54 (5.58)

51 (8.51)

0.03

70 (7.49)

97 (13.70)

0.81

 PVD

2 (0.09)

0 (0.00)

NA

1 (0.10)

1 (0.25)

NA

4 (0.30)

4 (0.55)

0.60

0 (0.00)

3 (0.50)

NA

4 (0.43)

5 (0.71)

1.00

 CVA

10 (0.45)

5 (0.90)

0.33

18 (1.76)

11 (2.74)

0.34

37 (2.74)

32 (4.40)

0.06

42 (4.34)

48 (8.01)

0.003

85 (9.09)

66 (9.32)

 < 0.001

 Dementia

0 (0.00)

0 (0.00)

NA

0 (0.00)

0 (0.00)

NA

3 (0.22)

0 (0.00)

NA

6 (0.62)

8 (1.34)

0.24

34 (3.64)

39 (5.51)

0.62

 COPD

6 (0.27)

1 (0.18)

NA

12 (1.18)

5 (1.24)

1.00

30 (2.22)

31 (4.26)

0.01

38 (3.93)

31 (5.18)

0.30

42 (4.49)

54 (7.63)

0.98

 CTD

20 (0.90)

27 (4.87)

 < 0.001

6 (0.59)

1 (0.25)

NA

13 (0.96)

15 (2.06)

0.06

13 (1.34)

5 (0.83)

0.50

6 (0.64)

12 (1.69)

0.55

 PUD

27 (1.22)

3 (0.54)

0.25

16 (1.57)

14 (3.48)

0.04

49 (3.63)

23 (3.16)

0.67

24 (2.48)

19 (3.17)

0.51

20 (2.14)

27 (3.81)

1.00

 Liver disease

24 (1.08)

20 (3.61)

 < 0.001

40 (3.92)

30 (7.46)

0.008

66 (4.89)

53 (7.29)

0.03

44 (4.55)

32 (5.34)

0.55

22 (2.35)

26 (3.67)

0.81

 DM

113 (5.09)

38 (6.86)

0.12

127 (12.45)

87 (21.64)

 < 0.001

282 (20.90)

227 (31.22)

 < 0.001

301 (31.10)

238 (39.73)

 < 0.001

273 (29.20)

259 (36.58)

 < 0.001

 CKD

24 (1.08)

12 (2.17)

0.07

49 (4.80)

24 (5.97)

0.44

88 (6.52)

75 (10.32)

0.003

121 (12.50)

97 (16.19)

0.05

199 (21.28)

158 (22.32)

 < 0.001

 Tumor

75 (3.38)

66 (11.91)

 < 0.001

168 (16.47)

132 (32.84)

 < 0.001

306 (22.68)

243 (33.43)

 < 0.001

223 (23.04)

171 (28.55)

0.02

183 (19.57)

147 (20.76)

 < 0.001

 Leukemia

7 (0.32)

5 (0.90)

0.13

0 (0.00)

2 (0.50)

NA

0 (0.00)

4 (0.55)

NA

1 (0.10)

2 (0.33)

0.67

0 (0.00)

2 (0.28)

NA

 Lymphoma

2 (0.09)

0 (0.00)

NA

5 (0.49)

4 (1.00)

0.48

6 (0.44)

2 (0.28)

0.82

1 (0.10)

4 (0.67)

0.14

1 (0.11)

6 (0.85)

0.25

 AIDS

14 (0.63)

15 (2.71)

 < 0.001

2 (0.20)

0 (0.00)

NA

2 (0.15)

1 (0.14)

1.00

2 (0.21)

2 (0.33)

1.00

0 (0.00)

0 (0.00)

NA

  1. Temp temperature, SBP systolic blood pressure, DBP diastolic blood pressure, RAPS Rapid Acute Physiology Score, qSOFA Sequential Organ Failure Assessment, CCI Charlson Comorbidity Index, PVD peripheral artery disease, GCS Glasgow Coma Scale, MI myocardial infarction, CHF congestive heart failure, PVD peripheral vascular disease, CVA cerebrovascular accident, COPD chronic obstructive pulmonary disease, CTD connective tissue disease, PUD peptic ulcer disease, DM diabetes mellitus, CKD chronic kidney disease, AIDS acquired immunodeficiency syndrome